Systemic Embolism clinical trials at University of California Health

1 in progress, 0 open to eligible people

Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination
“Volunteer for research and contribute to discoveries that may improve heart health for you, your family, and your community!”
Sorry, currently not accepting new patients, but might later
The purpose of this study is to compare the safety and effectiveness of Laminar Left Atrial Appendage Closure (LAAC) device as compared to the commercially available LAAC devices in participants with non-valvular atrial fibrillation (NVAF) to reduce the risk of stroke (blocked blood vessel or bleeding in brain) and systemic embolism (blockage in a blood vessel harming vital organs).
at UC Davis

Last updated: March 18, 2026

Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination